• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Obstetrics

Neonatal docosahexaenoic acid supplementation is associated with higher IQ scores at five years of age

byDavid XiangandKiera Liblik
October 31, 2022
in Obstetrics, Pediatrics
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. For infants born before 29 weeks gestation, the use of enteral docosahexaenoic acid (DHA) until 36 weeks of postpartum age was associated with a higher full-scale intelligence quotient (FSIQ) score at five years of age.

2. Adverse events were similar between infants who received 60mg of docosahexaenoic acid per kilogram of body weight and those who received a control emulsion.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Children who are born preterm are more likely to have lower cognitive scores and a higher risk of cognitive impairment than children born at full term. Infants born at the earliest gestational age are often deprived of the placental supply of DHA, which makes up approximately 30% of the lipid content of the brain. Current practice for preterm infants is to provide 20mg of DHA per kilogram of body weight per day, and previous trials have determined mostly null effects, but suggest a potential benefit for language at 18 to 22 months of corrected age. However, there is a gap in knowledge as to understanding the general cognitive functioning of infants born before 29 weeks’ gestation who utilized DHA. Overall, this study found that enteral emulsion of DHA at a dose of 60mg per kilogram per day was associated with a modestly higher FSIQ score at five years of age than those who received a control emulsion. This study was limited by higher-than-anticipated attrition and a range of ages at assessment that was wider than planned. Nevertheless, these findings are significant, as they demonstrate that supplementation of 60mg of DHA per kilogram per day for preterm infants born before 29 weeks gestation should be utilized to approximate the fetal required rate.

Click to read the study in the NEJM (New England Journal of Medicine)

Relevant Reading: Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants

RELATED REPORTS

Docosahexaenoic acid supplementation does not reduce risk of necrotizing enterocolitis among preterm infants

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

In-Depth [randomized control trial]: This multicenter, blinded, parallel-group, randomized control trial evaluated the effect of DHA feeding on bronchopulmonary dysplasia, and the study designers developed this follow-up study to study IQ. Patients who had not been withdrawn from the original trial or had not died were eligible for the trial. Patients who did not fit these criteria were excluded from the study. The primary outcome measured was the FSIQ score, assessed at five years of corrected age with the Wechsler Preschool and Primary Scale of Intelligence, administered by a psychologist or by trained technicians under the supervision of a psychologist in a hospital, the family home, or a local community center. Outcomes in the primary analysis were assessed via an intention-to-treat basis and the use of generalized linear models. Based on the primary analysis, a total of 480 patients had an FSIQ score available, with 241 in the DHA group and 239 in the control group. The mean FSIQ score was 95.4 in the DHA group and 91.9 in the control group (adjusted difference 3.45; 95% Confidence Interval 0.38 to 6.53). Adverse events were similar in the two groups, and though three deaths occurred, they were deemed to be unrelated to DHA or to protocol-directed activities. Overall, this study demonstrated that in children who had been before 29 weeks’ gestation, the mean FSIQ score at five years of corrected age was approximately 3.5 points higher in those who had received supplemental DHA compared to those who had received a control emulsion.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cognitive impairmentDHAdocosahexaenoic acidfull-scale intelligence quotientIQ scoreneonatologyobstetricspediatricspreterm birth
Previous Post

Sequencing of androgen-deprivation therapy with radiotherapy for non-metastatic prostate cancer

Next Post

Vitamin D3 supplementation not effective in preventing ventricular hypertrophy

RelatedReports

Newborn intensive care collage: a sleeping newborn in a knit cap, swaddled in a white blanket inside an incubator
Emergency

Docosahexaenoic acid supplementation does not reduce risk of necrotizing enterocolitis among preterm infants

November 3, 2026
Newborn health collage: a pair of knitted baby booties on a folded blanket below a teal paper heart
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Childhood illness and sleep collage: a girl asleep under a quilt with a teddy bear, a medicine bottle and a night-light
Pediatrics

Melatonin use is associated with lower proportions of rapid eye movement sleep in children

August 14, 2026
Blood pressure collage: a large artery cross-section ring, a tipped salt cellar spilling crystals and a plain wristwatch
Cardiology

A health coaching intervention may improve blood pressure control in postpartum women

August 12, 2026
Next Post
Heart disease in children collage: a smiling boy beside an engraved heart wrapped in a stethoscope

Vitamin D3 supplementation not effective in preventing ventricular hypertrophy

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact

Religiosity and spirituality may positively impact the well-being of kidney transplant recipients

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: The Last Dance, Head of State, Trouble on the Farm and the Heart of COVID-19!

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Interim global phase 2 AZUR-1 results show durable responses with dostarlimab monotherapy in untreated MSI-H/dMMR stage II/III locally advanced rectal cancer
  • AI health chatbot shows no benefit for perinatal anxiety or depression
  • ADCE-D01 showed a 30% objective response rate in topline phase 1 results for previously treated advanced soft tissue sarcoma
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.